Zhang Y - Search Results

1

Investigating esophageal sarcomatoid carcinoma and its comparison with esophageal squamous cell carcinoma on clinicopathological characteristics, prognosis, and radiomics features: a retrospective study.

Hu B, Zhao K, Yang Y, Zhang Y, Liu G, Zeng H, Zou B. Hu B, et al. Among authors: zhang y. Front Oncol. 2024 Jul 1;14:1398982. doi: 10.3389/fonc.2024.1398982. eCollection 2024. Front Oncol. 2024. PMID: 39011471 Free PMC article.

2

Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies.

Zhang Y, Li Q, Huang Z, Li B, Nice EC, Huang C, Wei L, Zou B. Zhang Y, et al. Cancers (Basel). 2022 Sep 21;14(19):4568. doi: 10.3390/cancers14194568. Cancers (Basel). 2022. PMID: 36230492 Free PMC article. Review.

3

[Radiation-Induced Heart Disease: Current Status and Challenges].

Yang HJ, Zhang Y, Peng O, Zou BW. Yang HJ, et al. Among authors: zhang y. Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Nov;53(6):1127-1134. doi: 10.12182/20221160302. Sichuan Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 36443063 Free PMC article. Review. Chinese.

4

Exploring Natural Products as Radioprotective Agents for Cancer Therapy: Mechanisms, Challenges, and Opportunities.

Zhang Y, Huang Y, Li Z, Wu H, Zou B, Xu Y. Zhang Y, et al. Cancers (Basel). 2023 Jul 12;15(14):3585. doi: 10.3390/cancers15143585. Cancers (Basel). 2023. PMID: 37509245 Free PMC article. Review.

5

Amplifying cancer treatment: advances in tumor immunotherapy and nanoparticle-based hyperthermia.

Zhang Y, Li Z, Huang Y, Zou B, Xu Y. Zhang Y, et al. Front Immunol. 2023 Oct 6;14:1258786. doi: 10.3389/fimmu.2023.1258786. eCollection 2023. Front Immunol. 2023. PMID: 37869003 Free PMC article. Review.

6

Radiation and resolve: unlocking the synergistic potential of radioimmunotherapy in advanced lung cancer management.

Zhang Y, Li Z, Zou B. Zhang Y, et al. Immunotherapy. 2024 Feb;16(2):55-58. doi: 10.2217/imt-2023-0268. Epub 2023 Dec 6. Immunotherapy. 2024. PMID: 38054261

7

Nanotechnology and curcumin: a novel and promising approach in digestive cancer therapy.

Zhang Y, Li Z, Huang Y, Xu Y, Zou B. Zhang Y, et al. Nanomedicine (Lond). 2023 Nov;18(27):2081-2099. doi: 10.2217/nnm-2023-0213. Epub 2023 Dec 11. Nanomedicine (Lond). 2023. PMID: 38078442 Review.

8

Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization.

Zhang Y, Liang L, Li Z, Huang Y, Jiang M, Zou B, Xu Y. Zhang Y, et al. Front Oncol. 2023 Dec 4;13:1295579. doi: 10.3389/fonc.2023.1295579. eCollection 2023. Front Oncol. 2023. PMID: 38111536 Free PMC article. Review.

9

Prognostic significance of cyclin-dependent kinase subunit 2 (CKS2) in malignant tumours: a meta-analysis and bioinformatic analysis.

Zhang Y, Li Z, Huang Y, Zou B, Xu Y. Zhang Y, et al. BMJ Open. 2024 Jan 31;14(1):e073887. doi: 10.1136/bmjopen-2023-073887. BMJ Open. 2024. PMID: 38296306 Free PMC article.

10

Letter to the Editor: Is the evidence convincing for the expansion of CHB treatment criteria to reduce the risk of HCC?

Li Z, Zhang Y, Li Y, Chen X, Hu J, Yu J, Hu Y, Nie S, Li N, Wen Q, Zou B. Li Z, et al. Among authors: zhang y. Hepatology. 2024 Sep 1;80(3):E37-E38. doi: 10.1097/HEP.0000000000000803. Epub 2024 Feb 19. Hepatology. 2024. PMID: 38373119 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261,435 results

Search Page

Filters